公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
1993 | Once-daily amlodipine on ambulatory blood pressure and regression of left ventricular hypertrophy in patients with mild to moderate essential hypertension | Chen J.-J.; HWANG, JUEY-JEN ; Schie J.-T.; Feng M.-H.; Chen T.-F.; Chen C.-C.; Tseng Y.-Z.; Kuan P.; Lien W.-P. | Acta Cardiologica Sinica | 2 | | |
2021 | Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial | Hsu Y.-C.; Chen C.-Y.; Chang I.-W.; Chang C.-Y.; Wu C.-Y.; Lee T.-Y.; MING-SHIANG WU ; Bair M.-J.; Chen J.-J.; CHIEH-CHANG CHEN ; Tseng C.-H.; Tai C.-M.; Huang Y.-T.; Ku W.-H.; Mo L.-R.; Lin J.-T. | The Lancet Infectious Diseases | 21 | 20 | |
2020 | An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients with Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated Substitutions | Huang C.-F.; Hung C.-H.; Cheng P.-N.; Bair M.-J.; Huang Y.-H.; JIA-HORNG KAO ; SHIH-JER HSU ; Lee P.-L.; Chen J.-J.; Chien R.-N.; Peng C.-Y.; Lin C.-Y.; Hsieh T.-Y.; Cheng C.-H.; Dai C.-Y.; Huang J.-F.; Chuang W.-L.; Yu M.-L. | Journal of Infectious Diseases | 15 | 11 | |
2017 | Pharmacogenetic dosing of warfarin in the Han-Chinese population: A randomized trial | Wen M.-S.; Chang K.-C.; Lee T.-H.; Chen Y.-F.; Hung K.-C.; Chang Y.-J.; Liou C.-W.; Chen J.-J.; Chang C.-H.; Wang C.-Y.; JIANN-SHING JENG ; Chuang H.-P.; Chen Y.-T.; Chen C.-H.; Wu J.-Y.; Chen Y.-T.; Lee M.T.M. | Pharmacogenomics | 33 | 29 | |
2016 | A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection | JIA-HORNG KAO ; Chien R.-N.; Chang T.-T.; Peng C.-Y.; Hu T.-H.; Lo G.-H.; Wang H.-Y.; Chen J.-J.; Yang J.C.; Knox S.J.; Han L.; Mo H.; Mathias A.; Brainard D.M.; Sheen I.-S.; Hsu Y.-C.; Chu C.-J.; Chuang W.-L. | Liver International | 25 | 25 | |
2008 | Plasma Concentration of SCUBE1, a Novel Platelet Protein, Is Elevated in Patients With Acute Coronary Syndrome and Ischemic Stroke | Dai D.-F.; Thajeb P.; Tu C.-F.; FU-TIEN CHIANG ; Chen C.-H.; Yang R.-B.; Chen J.-J. | Journal of the American College of Cardiology | 97 | 88 | |
2011 | Plasma levels of tumor necrosis factor-α and interleukin-6 are associated with diastolic heart failure through downregulation of sarcoplasmic reticulum Ca2+ ATPase | CHO-KAI WU ; JEN-KUANG LEE ; FU-TIEN CHIANG ; Yang C.-H.; Huang S.-W.; HWANG, JUEY-JEN ; JIUNN-LEE LIN ; Tseng C.-D.; Chen J.-J.; CHIA-TI TSAI | Critical Care Medicine | 96 | 96 | |
2012 | Potentials of lignocellulosic bioethanols produced from hardwood in Taiwan | Ko, Chun-Han ; Wang Y.-N. ; Chang F.-C.; Chen J.-J.; Chen W.-H.; Hwang, Wen-Song | Energy | 32 | 28 | |
2008 | Pravastatin attenuates carboplatin-induced cardiotoxicity via inhibition of oxidative stress associated apoptosis | Cheng C.-F.; Juan S.-H.; Chen J.-J.; Chao Y.-C.; Chen H.-H.; Lian W.-S.; CHUN-YI LU ; CHUNG-I CHANG ; Chiu T.-H.; Lin H. | Apoptosis | 61 | 49 | |
2008 | Proteasome Inhibitors Enhance TRAIL-Induced Apoptosis through the Intronic Regulation of DR5: Involvement of NF-κB and Reactive Oxygen Species-Mediated p53 Activation | Chen J.-J.; Chou C.-W.; Chang Y.-F.; CHING-CHOW CHEN | Journal of Immunology | 66 | 62 | |
2000 | Protein kinase Cα but not p44/42 mitogen-activated protein kinase, p38, or c-jun NH2-terminal kinase is required for intercellular adhesion molecule-1 expression mediated by intedeukin-1β: Involvement of sequential activation of tyrosine kinase, nuclear factor-κB-inducing kinase, and IκB kinase 2 | CHING-CHOW CHEN ; Chen J.-J.; Chou C.-Y. | Molecular Pharmacology | 68 | 69 | |
2010 | A randomized controlled trial of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced tardive dyskinesia | Chan H.-Y.; Chiang S.-C.; Chang C.-J.; SUSAN SHUR-FEN GAU ; Chen J.-J.; Chen C.-H.; Hwu H.-G.; Lai M.-S. | Journal of Clinical Psychiatry | 50 | 47 | |
2019 | Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study | CHEN-HUA LIU ; Yu M.-L.; Peng C.-Y.; Hsieh T.-Y.; Huang Y.-H.; Su W.-W.; Cheng P.-N.; Lin C.-L.; Lo C.-C.; Chen C.-Y.; Chen J.-J.; Ma Q.; Brooks-Rooney C.; JIA-HORNG KAO | Journal of the Formosan Medical Association | 8 | 8 | |
2012 | Risperidone and olanzapine versus another first generation antipsychotic in patients with schizophrenia inadequately responsive to first generation antipsychotics | Chen J.-J.; Chan H.-Y.; Chen C.-H.; SUSAN SHUR-FEN GAU ; Hwu H.-G. | Pharmacopsychiatry | 11 | 7 | |
1994 | Role of transesophageal echocardiography in the diagnostic assessment of cardiac sources of embolism in patients with acute ischemic stroke | Shyu K.-G.; Chen J.-J.; ZEI-SHUNG HUANG ; HWANG, JUEY-JEN ; Lee T.-K.; Kuan P.; Lien W.-P. | Cardiology (Switzerland) | 14 | 12 | |
2009 | Rupture of mitral chordae tendineae: Adding to the list of hypertension complications | JYH-MING JIMMY JUANG ; Ke S.-R.; JIUNN-LEE LIN ; HWANG, JUEY-JEN ; Hsu K.-L.; FU-TIEN CHIANG ; Tseng C.-D.; Tseng Y.-Z.; Chen J.-J.; Hu F.-C.; Lin Y.-T.; LING-PING LAI | Heart | 14 | 15 | |
1999 | A self-tuning run-by-run process controller for processes subject to random disturbances | Guo R.-S.; Chen J.-J.; Chen A.; Lu S.-S.; RUEY-SHAN GUO ; ARGON CHEN | Journal of the Chinese Institute of Engineers, Transactions of the Chinese Institute of Engineers,Series A/Chung-kuo Kung Ch'eng Hsuch K'an | 5 | 4 | |
1994 | Significant mitral regurgitation is protective against left atrial spontaneous echo contrast formation, but not against systemic embolism | HWANG, JUEY-JEN ; Shyu K.-G.; Hsu K.-L.; Chen J.-J.; Kuan P.; Lien W.-P. | Chest | 35 | 32 | |
2006 | A Single Nucleotide Polymorphism Fine Mapping Study of Chromosome 1q42.1 Reveals the Vulnerability Genes for Schizophrenia, GNPAT and DISC1: Association with Impairment of Sustained Attention | Liu Y.-L.; Fann C.S.-J.; Liu C.-M.; WEI J. CHEN ; Wu J.-Y.; Hung S.-I.; Chen C.-H.; Jou Y.-S.; Liu S.-K.; TZUNG-JENG HWANG ; MING-HSIEN HSIEH ; Ouyang W.-C.; Chan H.-Y.; Chen J.-J.; Yang W.-C.; Lin C.-Y.; Lee S.F.C.; Hwu H.-G. | Biological Psychiatry | 61 | 54 | |
2021 | Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan | CHEN-HUA LIU ; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; CHUN-JEN LIU ; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; YU-JEN FANG ; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; CHIEN-CHING HUNG ; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T. Y.; JIA-HORNG KAO | Hepatology International | 14 | 14 | |